29 April 2016 - The U.S. FDA today approved the first generic version of Crestor (rosuvastatin calcium).

Watson Pharmaceuticals has received approval to market generic rosuvastatin calcium in multiple strengths for the following uses: 

• In combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults
• In combination with diet for treatment of patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia), a disorder associated with improper breakdown of cholesterol and triglycerides
• Either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia, a disorder associated with high low-density lipoprotein (LDL) cholesterol

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm498373.htm